CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 

Cumulative Amgen Inc 's Total Debt to Equity for Trailing Twelve Months Period

AMGN's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

AMGN Total Debt to Equity for Trailing Twelve Months Period

(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Growth -22.63 % -1.59 % -2.73 % 0.29 % -1.25 %
Y / Y Total Debt Growth -4.21 % 2.63 % 10.31 % 15.09 % 11.79 %
Total Debt to Equity for Trailing Twelve Months Period 3.5 3.32 3.29 3.19 3.09
Total Ranking # 1888 # 1185 # 1176 # 1637 # 1836
Seq. Equity Growth -11.65 % -0.8 % -14.14 % 2.81 % 12.38 %
Seq. Total Debt Growth 0.3 % -0.91 % -3.79 % 0.18 % 7.46 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 0.3%, Total Debt to Equity for Trailing Twelve Months Period improved to 3.5, above Amgen Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 61 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Amgen Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 1185 to 1888.

What is Debt to Equity Ratio?
AMGN Charts and Quotes
Total Debt to Equity AMGN in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 62
Sector # 327
S&P 500 # 1883


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.38 0.4 0.01
(Sep. 30, 2014)   (Sep. 30, 2015)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Jun 30 2021, within Biotechnology & Pharmaceuticals Industry Total Debt to Equity for Trailing Twelve Months Period
Aerie Pharmaceuticals Inc   8.43 
Abbvie Inc   6.07 
Cannabis Global Inc   5.39 
Halozyme Therapeutics Inc   5.11 
Pactiv Evergreen Inc   4.66 
Amgen Inc   3.42 
Axim Biotechnologies Inc   3.40 
Coherus Biosciences inc   1.90 
Avantor Inc   1.88 
Aptevo Therapeutics Inc   1.56 
Gilead Sciences Inc   1.53 
Reynolds Consumer Products Inc   1.42 
Genocea Biosciences Inc   1.37 
Cellular Biomedicine Group Inc   1.35 
Nanostring Technologies Inc   1.17 
Adma Biologics Inc   1.04 
Surgalign Holdings Inc   0.99 
Acorda Therapeutics inc   0.86 
Akoya Biosciences Inc   0.76 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CODA's Profile

Stock Price

CODA's Financials

Business Description

Fundamentals

Charts & Quotes

CODA's News

Suppliers

CODA's Competitors

Customers & Markets

Economic Indicators

CODA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071